Immix Biopharma (IMMX) Cash & Equivalents (2020 - 2026)
Quarterly results put Cash & Equivalents at $79.3 million for Q1 2026, up 397.77% from a year ago — trailing twelve months through Mar 2026 was $79.3 million (up 397.77% YoY), and the annual figure for FY2025 was $93.9 million, up 431.21%.
Immix Biopharma has reported Cash & Equivalents over the past 7 years, most recently at $79.3 million for Q1 2026.
- Cash & Equivalents reached $79.3 million in Q1 2026 per IMMX's latest filing, down from $93.9 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $93.9 million in Q4 2025 and bottomed at $11.5 million in Q1 2023.
- Median Cash & Equivalents over the past 5 years was $18.0 million (2022), compared with a mean of $26.4 million.
- Peak annual rise in Cash & Equivalents hit 431.21% in 2025, while the deepest fall reached 51.62% in 2025.
- Over 5 years, Cash & Equivalents stood at $16.9 million in 2022, then rose by 3.51% to $17.5 million in 2023, then grew by 0.98% to $17.7 million in 2024, then surged by 431.21% to $93.9 million in 2025, then fell by 15.63% to $79.3 million in 2026.
- Business Quant data shows Cash & Equivalents for IMMX at $79.3 million in Q1 2026, $93.9 million in Q4 2025, and $15.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 1.91 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 901.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 5.49 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 2.96 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.71 Bn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | 79.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.25 Mn |
| Dec 31, 2025 | 93.93 Mn |
| Sep 30, 2025 | 15.90 Mn |
| Jun 30, 2025 | 11.60 Mn |
| Mar 31, 2025 | 15.92 Mn |
| Dec 31, 2024 | 17.68 Mn |
| Sep 30, 2024 | 19.69 Mn |
| Jun 30, 2024 | 23.98 Mn |
| Mar 31, 2024 | 29.32 Mn |
| Dec 31, 2023 | 17.51 Mn |
| Sep 30, 2023 | 19.58 Mn |
| Jun 30, 2023 | 12.65 Mn |
| Mar 31, 2023 | 11.46 Mn |
| Sep 30, 2022 | 16.92 Mn |
| Jun 30, 2022 | 18.40 Mn |
| Mar 31, 2022 | 19.06 Mn |
| Dec 31, 2021 | 17.64 Mn |
| Dec 31, 2020 | 391,086.00 |